Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Return on Equity (2022 - 2025)

Bioregenx's Return on Equity history spans 4 years, with the latest figure at 0.38% for Q4 2025.

  • Quarterly results put Return on Equity at 0.38% for Q4 2025, up 442.0% from a year ago — trailing twelve months through Dec 2025 was 0.38% (up 442.0% YoY), and the annual figure for FY2025 was 0.39%, down 807.0%.
  • Return on Equity for Q4 2025 was 0.38% at Bioregenx, down from 5.18% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 5.81% in Q1 2025 to a low of 4.05% in Q4 2024.
  • The 4-year median for Return on Equity is 0.1% (2023), against an average of 0.94%.
  • The sharpest move saw Return on Equity crashed -444bps in 2024, then skyrocketed 603bps in 2025.
  • Year by year, Return on Equity stood at 0.06% in 2022, then soared by 584bps to 0.39% in 2023, then tumbled by -1129bps to 4.05% in 2024, then surged by 109bps to 0.38% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.38%, 5.18%, and 5.33% for Q4 2025, Q3 2025, and Q2 2025 respectively.